Treatment of Nasopharyngeal Carcinoma: Stereotactic Radiosurgical Boost following Fractionated Radiotherapy
- 1 January 1999
- journal article
- radiosurgery
- Published by S. Karger AG in Stereotactic and Functional Neurosurgery
- Vol. 73 (1-4) , 64-67
- https://doi.org/10.1159/000029753
Abstract
Treatment of patients with nasopharyngeal carcinoma (NPC) using external beam radiation therapy (XRT) alone results in significant local recurrence. To improve local control, stereotactic radiosurgery (SRS) was used to boost radiation to the primary tumor site following XRT in 23 patients with NPC. SRS was delivered utilizing a frame-based linear accelerator as a boost (range 7–15 Gy, median 12 Gy) following XRT (range 64.8– 70 Gy, median 66 Gy). In all 23 patients (100%) receiving SRS following XRT local control was achieved at a mean follow-up of 21 months (range 2–64 months). There have been no complications of treatment caused by SRS. However, 8 patients (35%) have subsequently developed regional or distant metastases. SRS boost following XRT provides excellent local control in NPC and should be considered for patients with skull base involvement.Keywords
This publication has 2 references indexed in Scilit:
- Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: First clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palateInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional controlInternational Journal of Radiation Oncology*Biology*Physics, 1997